Boehringer’s deal spree; Praxis’ licensing pact with Shanghai biotech; Vico Therapeutics raises $60Mnews2024-01-05T15:23:27+00:00January 5th, 2024|Endpoints News|
Psychedelic-assisted drug developer MAPS PBC nabs $100M, renames to Lykos Therapeuticsnews2024-01-05T13:00:16+00:00January 5th, 2024|Endpoints News|
AlloVir lays off 95% of workers after canceling PhIII antiviral cell therapy studiesnews2024-01-05T12:20:13+00:00January 5th, 2024|Endpoints News|
Evotec CEO Werner Lanthaler resigns; After Novo deal, ex-Forma chief ushers in new era at Paciranews2024-01-05T12:02:59+00:00January 5th, 2024|Endpoints News|
Intellia Therapeutics cuts 15% of workforce, extends cash runway into mid-2026news2024-01-05T12:02:54+00:00January 5th, 2024|Endpoints News|
Applied Therapeutics’ diabetic cardiomyopathy drug fails at PhIII, sparking partnership huntnews2024-01-05T11:54:42+00:00January 5th, 2024|Endpoints News|
Allogene Therapeutics to restructure, deprioritize PhII CAR-T trials in clinical pivotnews2024-01-05T11:04:37+00:00January 5th, 2024|Endpoints News|
Feng Zhang’s CRISPR startup Aera shrinks headcount by a quarternews2024-01-05T04:49:10+00:00January 5th, 2024|Endpoints News|
Delfi Diagnostics hires Illumina’s chief commercial officer as next CEOnews2024-01-04T23:17:38+00:00January 4th, 2024|Endpoints News|
UCB departs industry trade group BIO, following Pfizer’s exit late last yearnews2024-01-04T20:29:33+00:00January 4th, 2024|Endpoints News|
